RHEUMATIC JOINT DISEASE
Clinical trials for RHEUMATIC JOINT DISEASE explained in plain language.
Never miss a new study
Get alerted when new RHEUMATIC JOINT DISEASE trials appear
Sign up with your email to follow new studies for RHEUMATIC JOINT DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug hopes to ease joint pain for arthritis sufferers
Disease control Recruiting nowThis study tests a new medicine called SPY002-072 in adults with moderate-to-severe rheumatoid arthritis, psoriatic arthritis, or axial spondyloarthritis. About 285 participants will receive either the drug or a placebo to see if it reduces joint swelling and pain. The goal is to…
Matched conditions: RHEUMATIC JOINT DISEASE
Phase: PHASE2 • Sponsor: Spyre Therapeutics, Inc. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Massive 20,000-Child study aims to unlock secrets of juvenile arthritis treatments
Knowledge-focused Recruiting nowThis study is creating a long-term registry to track children and young adults with rheumatic diseases like juvenile arthritis. Researchers will follow up to 20,000 participants for 10+ years to collect information about their treatments, side effects, and health outcomes. The go…
Matched conditions: RHEUMATIC JOINT DISEASE
Sponsor: Duke University • Aim: Knowledge-focused
Last updated Apr 13, 2026 20:20 UTC